Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Agios Pharmaceuticals
Agios Pharmaceuticals Appoints Charles Sawyers, M.D., to Scientific Advisory Board
February 27th, 2009
Agios Pharmaceuticals, the first biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, announced the appointment of Charles Sawyers, M.D., to its scientific advisory board. Dr. Sawyers, who currently serves as Chairman of Memorial Sloan-Kettering Cancer Center's Human Oncology and Pathogenesis Program, is an internationally recognized clinician and scientist who led the clinical development of two breakthrough cancer therapies, Gleevec (imatinib) and Sprycel (dasatinib). "We are excited to have Dr. Sawyers join the Agios scientific advisory board to help accelerate our exploration of the...
Source: Health Business Week (2009-02-27)
|
